Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue

Molecular Pain

Volumn 6, Issue , 2010, Pages

  Ip, Virginia ^a   Liu, Johnson J ^a   Mercer, Julian F B ^b   McKeage, Mark J ^a  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; MENKES PROTEIN; MESSENGER RNA; OXALIPLATIN; PROTEIN CTR1; UNCLASSIFIED DRUG; WILSON DISEASE PROTEIN; ADENOSINE TRIPHOSPHATASE; ATP7A PROTEIN, RAT; ATP7B PROTEIN, RAT; CATION TRANSPORT PROTEIN; PLATINUM COMPLEX; SLC31A1 PROTEIN, RAT;

ADVERSE OUTCOME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEUROFILAMENT; NEUROTOXICITY; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINAL GANGLION; TISSUE LEVEL; TISSUE SPECIFICITY; WESTERN BLOTTING; AGING; ANIMAL; CELL SIZE; CYTOLOGY; DRUG EFFECT; GENETICS; LUMBAR VERTEBRA; METABOLISM; NERVE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT;

ADENOSINE TRIPHOSPHATASES; AGING; ANIMALS; CATION TRANSPORT PROTEINS; CELL SIZE; FEMALE; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; LUMBAR VERTEBRAE; NEURONS; ORGANOPLATINUM COMPOUNDS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77956476273     PISSN: 17448069     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-8069-6-53     Document Type: Article

References (61)

1. Linder MC, HazeghAzam M. Copper biochemistry and molecular biology. American Journal of Clinical Nutrition 1996, 63:S797-S811.
2. Camakaris J, Voskoboinik I, Mercer JF. Molecular mechanisms of copper homeostasis. Biochemical and Biophysical Research Communications 1999, 261:225-232. 10.1006/bbrc.1999.1073, 10425169.
3. Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY. Function and regulation of human copper-transporting ATPases. Physiological Reviews 2007, 87:1011-1046. 10.1152/physrev.00004.2006, 17615395.
4. Lee J, Pena MMO, Nose Y, Thiele DJ. Biochemical characterization of the human copper transporter Ctr1. Journal of Biological Chemistry 2002, 277:4380-4387. 10.1074/jbc.M104728200, 11734551.
5. Barnes N, Tsivkovskii R, Tsivkovskaia N, Lutsenko S. The copper-transporting ATPases, Menkes and Wilson disease proteins, have distinct roles in adult and developing cerebellum. Journal of Biological Chemistry 2005, 280:9640-9645. 10.1074/jbc.M413840200, 15634671.
6. Platonova NA, Barabanova SV, Povalikhin RG, Tsymbalenko NV, Danilovskii MA, Voronina OV, Puchkova LV. In vivo expression of copper-transporting proteins in rat brain regions. Biology Bulletin 2005, 32:108-120.
7. Waggoner DJ, Bartnikas TB, Gitlin JD. The role of copper in neurodegenerative disease. Neurobiology of Disease 1999, 6:221-230. 10.1006/nbdi.1999.0250, 10448050.
8. Karmy G, Carr PA, Yamamoto T, Chan SHP, Nagy JI. Cytochrome-oxidase immunohistochemistry in rat-brain and dorsal-root ganglia-visualization of enzyme in neuronal perikarya and in parvalbumin-positive neurons. Neuroscience 1991, 40:825-839. 10.1016/0306-4522(91)90015-G, 1648184.
9. Rosenfeld J, Cook S, James R. Expression of superoxide dismutase following axotomy. Experimental Neurology 1997, 147:37-47. 10.1006/exnr.1997.6604, 9294401.
10. Jeng AY, Fujimoto RA, Chou M, Tan J, Erion MD. Suppression of substance P biosynthesis in sensory neurons of dorsal root ganglion by prodrug esters of potent peptidylglycine alpha-amidating monooxygenase inhibitors. Journal of Biological Chemistry 1997, 272:14666-14671. 10.1074/jbc.272.23.14666, 9169429.
11. Zara G, Grassivaro F, Brocadello F, Manara R, Pesenti FF. Case of sensory ataxic ganglionopathy-myelopathy in copper deficiency. Journal of the Neurological Sciences 2009, 277:184-186. 10.1016/j.jns.2008.10.017, 19022461.
12. Khaleeli Z, Healy DG, Briddon A, Lunn MP, Reilly MM, Land J, Giovannoni G. Lesson of the Week Copper deficiency as a treatable cause of poor balance. British Medical Journal 2010, 340:5.
13. Ishida S, Lee J, Thiele DJ, Herskowitz I. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:14298-14302. 10.1073/pnas.162491399, 137878, 12370430.
14. Lin XJ, Okuda T, Holzer A, Howell SB. The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae. Molecular Pharmacology 2002, 62:1154-1159. 10.1124/mol.62.5.1154, 12391279.
15. Holzer AK, Samimi G, Katano K, Naerdemann W, Lin XJ, Safaei R, Howell SB. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells. Molecular Pharmacology 2004, 66:817-823. 10.1124/mol.104.001198, 15229296.
16. Katano K, Safaei R, Samimi G, Holzer A, Rochdi M, Howell SB. The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells. Molecular Pharmacology 2003, 64:466-473. 10.1124/mol.64.2.466, 12869652.
17. Samimi G, Katano K, Holzer AK, Safaei R, Howell SB. Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B. Molecular Pharmacology 2004, 66:25-32. 10.1124/mol.66.1.25, 15213293.
18. Samimi G, Safaei R, Katano K, Holzer AK, Rochdi M, Tomioka M, Goodman M, Howell SB. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clinical Cancer Research 2004, 10:4661-4669. 10.1158/1078-0432.CCR-04-0137, 15269138.
19. Safaei R, Otani S, Larson BJ, Rasmussen ML, Howell SB. Transport of cisplatin by the copper efflux transporter ATP7B. Molecular Pharmacology 2008, 73:461-468. 10.1124/mol.107.040980, 17978167.
20. Kalayda GV, Wagner CH, Buss I, Reedijk J, Jaehde U. Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells. BMC Cancer 2008, 8:12. 10.1186/1471-2407-8-175, 2242792, 18199340.
21. Gregg RW, Molepo JM, Monpetit VJA, Mikael NZ, Redmond D, Gadia M, Stewart DJ. Cisplatin neurotoxicity-The relationship between dosage, time, and platinum concentration in neurologic tissues, and morphological evidence of toxicity. Journal of Clinical Oncology 1992, 10:795-803.
22. Screnci D, McKeage MJ, Galettis P. Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs. British Journal of Cancer 2000, 82:966-972. 10.1054/bjoc.1999.1026, 2374394, 10732773.
23. Cavaletti G, Tredici G, Pizzini G, Minoia A. Tissue platinum concentrations and cisplatin schedules. Lancet 1990, 336:1003-1003. 10.1016/0140-6736(90)92462-Q, 1976980.
24. Krarup-Hansen A, Rietz B, Krarup C, Heydorn K, Rorth M, Schmalbruch H. Histology and platinum content of sensory ganglia and sural nerves in patients treated with cisplatin and carboplatin: an autopsy study. Neuropathology and Applied Neurobiology 1999, 25:29-40. 10.1046/j.1365-2990.1999.00160.x, 10194773.
25. McKeage MJ, Hsu T, Screnci D, Haddad G, Baguley BC. Nucleolar damage correlates with neurotoxicity induced by different platinum drugs. British Journal of Cancer 2001, 85:1219-1225. 10.1054/bjoc.2001.2024, 2375155, 11710838.
26. Jamieson SMF, Liu J, Connor B, McKeage MJ. Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss. Cancer Chemotherapy and Pharmacology 2005, 56:391-399. 10.1007/s00280-004-0953-4, 15887017.
27. Krarup-Hansen A, Helweg-Larsen S, Schmalbruch H, Rorth M, Krarup C. Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies. Brain 2007, 130:1076-1088. 10.1093/brain/awl356, 17301082.
28. Cavaletti G, Tredici G, Marmiroli P, Petruccioli MG, Barajon I, Fabbrica D. Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats. Acta Neuropathologica 1992, 84:364-371. 10.1007/BF00227662, 1441917.
29. Tomiwa K, Nolan C, Cavanagh JB. The effects of cisplatin on rat spinal ganglia - A study by light and electron-microscopy and by morphometry. Acta Neuropathologica 1986, 69:295-308. 10.1007/BF00688308, 3962607.
30. Thompson SW, Davis LE, Kornfeld M, Hilgers RD, Standefer JC. Cisplatin neuropathy - Clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer 1984, 54:1269-1275. 10.1002/1097-0142(19841001)54:7<1269::AID-CNCR2820540707>3.0.CO;2-9, 6088023.
31. Roelofs RI, Hrushesky W, Rogin J, Rosenberg L. Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology 1984, 34:934-938.
32. Cavaletti G, Tredici G, Petruccioli MG, Donde E, Tredici P, Marmiroli P, Minoia C, Ronchi A, Bayssas M, Etienne GG. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. European Journal of Cancer 2001, 37:2457-2463. 10.1016/S0959-8049(01)00300-8, 11720843.
33. Holmes J, Stanko J, Varchenko M, Ding H, Madden VJ, Bagnell CR, Wyrick SD, Chaney SG. Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model. Toxicological Sciences 1998, 46:342-351.
34. Windebank AJ. Chemotherapeutic neuropathy. Current Opinion in Neurology 1999, 12:565-571. 10.1097/00019052-199910000-00010, 10590893.
35. Liu JJ, Jamieson SMF, Subramaniam J, Ip V, Jong NN, Mercer JFB, McKeage MJ. Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity. Cancer Chemotherapy and Pharmacology 2009, 64:847-856. 10.1007/s00280-009-1017-6, 19466412.
36. Muller LJ, Vanderhoop RG, Moorervandelft CM, Gispen WH, Roubos EW. Morphological and electrophysiological study of the effects of cisplatin and ORG.2766 on rat spinal ganglion neurons. Cancer Research 1990, 50:2437-2442.
37. Jamieson SMF, Subramaniam J, Liu JJ, Jong NN, Ip V, Connor B, McKeage MJ. Oxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissue. Molecular Pain 2009, 5:9. 10.1186/1744-8069-5-66, 2655284, 19245717.
38. Goss JA, Barshes NR, Karpen SJ, Gao FQ, Wyllie S. Liver ischemia and ischemia-reperfusion induces and trafficks the multi-specific metal transporter Atp7b to bile duct canaliculi: Possible preferential transport of iron into bile. Biological Trace Element Research 2008, 122:26-41. 10.1007/s12011-007-8057-8, 17987273.
39. Holzer AK, Varki NM, Le QT, Gibson MA, Naredi P, Howell SB. Expression of the human copper influx transporter 1 in normal and malignant human tissues. Journal of Histochemistry & Cytochemistry 2006, 54:1041-1049.
40. El Meskini R, Culotta VC, Mains RE, Eipper BA. Supplying copper to the cuproenzyme peptidylglycine alpha-amidating monooxygenase. Journal of Biological Chemistry 2003, 278:12278-12284. 10.1074/jbc.M211413200, 12529325.
41. Hansel DE, May V, Eipper BA, Ronnett GV. Pituitary adenylyl cyclase-activating peptides and alpha-amidation in olfactory neurogenesis and neuronal survival in vitro. Journal of Neuroscience 2001, 21:4625-4636.
42. Steveson TC, Ciccotosto GD, Ma XM, Mueller GP, Mains RE, Eipper BA. Menkes protein contributes to the function of peptidylglycine alpha-amidating monooxygenase. Endocrinology 2003, 144:188-200. 10.1210/en.2002-220716, 12488345.
43. Wong M, Jeng AY. Posttranslational modification of glycine-extended substance-P by an alpha-amidating enzyme in cultured sensory neurons of dorsal-root-ganglia. Journal of Neuroscience Research 1994, 37:97-102. 10.1002/jnr.490370113, 7511706.
44. Erion MD, Tan J, Wong M, Jeng AY. Inhibition of peptidyglycine alpha-amidating monooxygenase by N-substituted homocysteine analogs. Journal of Medicinal Chemistry 1994, 37:4430-4437. 10.1021/jm00052a002, 7528281.
45. Hokfelt T, Kellerth JO, Nilsson G, Pernow B. Substance-P-Localization in central nervous-system and in some primary sensory neurons. Science 1975, 190:889-890. 10.1126/science.242075, 242075.
46. McCarthy PW, Lawson SN. Cell type and conduction-velocity of rat primary sensory neurons with substance P-like immunoreactivity. Neuroscience 1989, 28:745-753. 10.1016/0306-4522(89)90019-5, 2469036.
47. Lee LW, Prohaska JR, Thiele DJ. Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:6842-6847. 10.1073/pnas.111058698, 34440, 11391005.
48. Kim H, Son HY, Bailey SM, Lee J. Deletion of hepatic Ctr1 reveals its function in copper acquisition and compensatory mechanisms for copper homeostasis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2009, 296:G356-G364. 10.1152/ajpgi.90632.2008, 2643901, 19095764.
49. Gardiner NJ, Wang Z, Luke C, Gott A, Price SA, Fernyhough P. Expression of hexokinase isoforms in the dorsal root ganglion of the adult rat and effect of experimental diabetes. Brain Research 2007, 1175:143-154. 10.1016/j.brainres.2007.08.015, 17803972.
50. Cavaletti G, Fabbrica D, Minoia C, Frattola L, Tredici G. Carboplatin toxic effects on the peripheral nervous system of the rat. Annals of Oncology 1998, 9:443-447. 10.1023/A:1008231925889, 9636837.
51. Daugaard GK, Petrera J, Trojaborg W. Eletrophysiological study of the peripheral and central neurotoxic effects of cisplatin. Acta Neurologica Scandinavica 1987, 76:86-93. 10.1111/j.1600-0404.1987.tb03551.x, 3673502.
52. Screnci D, Er HM, Hambley TW, Galettis P, Brouwer W, McKeage MJ. Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin. British Journal of Cancer 1997, 76:502-510. 2227979, 9275028.
53. Harper AA, Lawson SN. Conduction-velocity is related to morphological cell type in rat dorsal-root gangliob neurons. Journal of Physiology-London 1985, 359:31-&.
54. Kishi M, Tanabe J, Schmelzer JD, Low PA. Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy. Diabetes 2002, 51:819-824. 10.2337/diabetes.51.3.819, 11872686.
55. Lee KH, Chung KS, Chung JM, Coggeshall RE. Corrlation of cell body size, axon size, and signal conduction-velocity for individually labeled dorsal-root ganglion-cells in the cat. Journal of Comparative Neurology 1986, 243:335-346. 10.1002/cne.902430305, 3950079.
56. Holzer AK, Howell SB. The internalization and degradation of human copper transporter 1 following cisplatin exposure. Cancer Research 2006, 66:10944-10952. 10.1158/0008-5472.CAN-06-1710, 17108132.
57. Holzer AK, Katano K, Klomp LWJ, Howell SB. Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells. Clinical Cancer Research 2004, 10:6744-6749. 10.1158/1078-0432.CCR-04-0748, 15475465.
58. Liu JJ, Galettis P, Farr A, Maharaj L, Samarasinha H, McGechan AC, Baguley BC, Bowen RJ, Berners-Price SJ, McKeage MJ. In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to cellular uptake. Journal of Inorganic Biochemistry 2008, 102:303-310. 10.1016/j.jinorgbio.2007.09.003, 18029019.
59. Liu WH, Saint DA. Validation of a quantitative method for real time PCR kinetics. Biochemical and Biophysical Research Communications 2002, 294:347-353. 10.1016/S0006-291X(02)00478-3, 12051718.
60. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-rrCt method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
61. Bergman E, Ulfhake B. Loss of primary sensory neurons in the very old rat: Neuron number estimates using the disector method and confocal optical sectioning. Journal of Comparative Neurology 1998, 396:211-222. 10.1002/(SICI)1096-9861(19980629)396:2<211::AID-CNE6>3.0.CO;2-3, 9634143.